Microbix Biosystems Inc.
MBX.TOTSXHealthcare● Active
$0.27
+$0.00(+0.00%)
Market Cap$37409310
P/E Ratio—
52W High$0.34
52W Low$0.21
Microbix Biosystems Inc. (MBX.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MBX.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $18.59M | $25.39M | $16.51M | $19.08M | $18.59M |
| Cost of Revenue | $8.73M | $10.00M | $9.03M | $7.95M | $7.55M |
| Gross Profit | $9.85M | $15.39M | $7.48M | $11.12M | $11.04M |
| Gross Margin %(computed) | 53.02% | 60.61% | 45.30% | 58.32% | 59.40% |
| Operating Expenses | |||||
| R&D Expenses | $2.33M | $2.13M | $2.05M | $1.80M | $1.03M |
| G&A Expenses | $0.00M | $8.63M | $6.53M | $5.00M | $4.22M |
| Total Operating Expenses | $11.43M | $11.49M | $10.22M | $8.51M | $6.21M |
| Operating Income | ($1.58M) | $3.91M | ($2.74M) | $2.69M | $4.84M |
| Operating Margin %(computed) | -8.48% | 15.38% | -16.57% | 14.11% | 26.01% |
| Interest Income | $0.35M | $0.69M | $0.46M | $0.08M | $0.00M |
| Interest Expense | $0.95M | $0.92M | $0.84M | $0.83M | $1.60M |
| Income Before Tax | ($2.30M) | $3.67M | ($0.04M) | $1.87M | $3.23M |
| Income Tax Expense | ($0.06M) | $0.15M | $0.00M | $0.08M | $1.60M |
| Net Income | ($2.25M) | $3.52M | ($0.04M) | $1.79M | $1.63M |
| Net Margin %(computed) | -12.08% | 13.86% | -0.24% | 9.38% | 8.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $0.03 | $-0.00 | $0.01 | $0.01 |
| Wtd Avg Shares | 139.15M | 136.70M | 137.91M | 135.38M | 114.85M |
| EBITDA | $0.43M | $6.21M | $1.96M | $3.73M | $5.66M |
| EBITDA Margin %(computed) | 2.30% | 24.44% | 11.85% | 19.55% | 30.43% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more Microbix Biosystems Inc. data
About Microbix Biosystems Inc. (MBX.TO) Income Statement
Microbix Biosystems Inc. (MBX.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MBX.TO reported revenue of $0.02B, gross profit of $0.01B (gross margin 53.02%), and net income of ($0.00B) — a net profit margin of -12.08%.
Frequently asked questions
MBX.TO · 4 questionsMicrobix Biosystems Inc. (MBX.TO) reported revenue of $0.02B for 2025, down 26.8% year-over-year.
MBX.TO revenueMBX.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08